Akari Therapeutics Files Prospectus Related To Resale Of Up To 6M ADSs Representing 480B Ordinary Shares By The Selling Shareholders
SEC Filing
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.